Search

everythinglearnresearchcommunity

for

Search:↓

Proteins like aPKC and PDGF-AA, substances like adenosine and ATP, and adipose-derived stem cells all play important roles in hair growth and health, and could potentially be used to treat hair loss and skin conditions.

Accurate diagnosis of cicatricial alopecias requires thorough scalp examination and multiple biopsy techniques.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

Alopecia patients have more mast cells in their scalps, especially in severe cases and older age, with alopecia areata showing the highest increase.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

To treat tinea capitis in children, oral antifungal medication is necessary, with newer drugs offering shorter treatment times than the traditional griseofulvin.

Stem cells are key for hair follicle recovery.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Corneodesmosin is essential for skin and hair health, and its dysfunction can lead to skin and hair disorders.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Targeting Vδ1+T-cells may help treat alopecia areata.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Botulinum toxin shows promise for treating scalp sweating but not for hair growth.

Adiponectin reduces hair pigmentation and affects hair growth signals.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Plucked hair follicles can help diagnose scalp lupus.

CD28 is a promising target for treating alopecia areata with belatacept.

CD28 is a promising target for treating alopecia areata with belatacept.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

Understanding skin microbes and sebum can help manage atopic dermatitis and hair loss.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Higher activity in lichen planopilaris is linked to certain immune and tissue genes.

Human scalp hair follicles can produce hormones and have a system similar to a brain-body communication network.

Automated image analysis helps diagnose and monitor alopecia areata by efficiently measuring hair follicles.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.